drug · small molecule
emestedastat
Phase 3updated 3mo agoby Actinogen Medical Ltd🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
indications
indications
Alzheimer's Disease
all catalysts(0)
nothing on the calendar yet
Trials studying emestedastat
- phase3Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
- phase2A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)
- phase2A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers
- phase1Xanamem™ in Healthy Elderly Subjects
- phase2Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 45m ago
Found something off?
comments(0)
5-min edit window · permanent after that